By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novogen Limited 

140 Wicks Road

North Ryde    NSW 2113  Australia
Phone: 203-327-1188 Fax: 203-327-0011



Company News
Novogen Limited (NVGN) Provides Update On Development Of Cantrixil 5/2/2016 6:53:29 AM
Novogen Limited (NVGN) Receives R&D Tax Incentive Cash Refund 3/17/2016 7:38:43 AM
Novogen Limited (NVGN) Patent Covering Cantrixil And Trilexium Has Proceeded To Grant 2/19/2016 6:08:38 AM
Novogen Limited (NVGN) Announces Changes To The Board With New Chairman And Deputy Chairman Appointed 2/5/2016 6:22:35 AM
Novogen Limited (NVGN) Appoints Dr James Garner As Chief Executive Officer 12/10/2015 6:30:59 AM
Novogen Limited (NVGN) Engages Contract Research Organisation To Conduct Cantrixil Phase 1 Clinical Trial 11/24/2015 6:17:35 AM
Novogen Limited (NVGN) Patent Covering Cantrixil And Trilexium Accepted In Australia 11/12/2015 7:41:57 AM
Novogen Limited (NVGN) Release: Preclinical Studies Justify Mode Of Delivery And Dosing Regimen For Anisina 11/11/2015 6:55:10 AM
Novogen Limited (NVGN) Announces The Outcome Of A Comprehensive Science Review 8/31/2015 7:32:52 AM
Newly Appointed Acting CEO Outlines Immediate Plans For Novogen Limited (NVGN) 7/31/2015 8:56:29 AM